Last10K.com

Acrongenomics Inc (AGNM) SEC Filing 10-Q Quarterly report for the period ending Wednesday, March 31, 2010

Acrongenomics Inc

HISTORY TOOLS
CIK: 1104502 Ticker: AGNM

View differences made from one quarter to another to evaluate Acrongenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acrongenomics Inc.

Continue

Assess how Acrongenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acrongenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: AGNM
CIK: 1104502
Form Type: 10-Q Quarterly Report
Accession Number: 0001062993-10-001653
Submitted to the SEC: Mon May 17 2010 4:02:13 PM EST
Accepted by the SEC: Mon May 17 2010
Period: Wednesday, March 31, 2010
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/agnm/0001062993-10-001653.htm